Hi DougeTX. I of course don't know how many share this board holds factually but if you just go by the amount of members of this board, not counting anyone that hasn't hit the follow button for this board, for instance if we have 35 followers here and we estimate an average of 20 mill. Per follower then a rough estimate would be 700 mill.. As for using this to evaluate himr's view on the importance of their shareholders I will say this, kgem, junebug, GM, and I have used this to our advantage before and I believe we all honestly believe that himr cares about its shareholders. But to be clear, greed can change this view as it could any company's view of its shareholders when success or failure comes. One should always keep a guard up just in case. If I'm wrong about my assumption kgem, junebug, or GM I'm sorry.
Hi DougeTX. I of course don't know how many share this
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SmartFinancial Announces Earnings Release and Call Schedule
SmartFinancial Announces Upcoming Earnings Release SmartFinancial, Inc. (NYSE: SMBK) has revealed important details regarding its Fourth Quarter earnings for the year 2024. This is an exciting time for investors and stakeholders as the company prepares to share insights into its financial performance. Earnings Release Date and Conference Call Information The earnings...
Continue Reading
IntouchCX Enhances Trust and Safety with WebPurify Acquisition
IntouchCX Strengthens Trust and Safety Solutions Through Acquisition IntouchCX has recently made headlines with its acquisition of WebPurify, a leading provider of innovative content moderation solutions that harness the power of artificial intelligence. This strategic move represents a significant advancement in IntouchCX's mission to redefine Trust and Safety solutions,...
Continue Reading
Y-mAbs Therapeutics to Present at Key Investor Conferences
Y-mAbs Therapeutics Engages Investors at Upcoming Conferences This September, Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a key player in the biopharmaceutical industry, is poised to attract investor interest. The company is known for its innovative radioimmunotherapy and antibody-based treatments designed to transform cancer care. Michael Rossi, the energetic CEO of...
Continue Reading
CorVel Corporation Reports Strong Financial Growth
Overview of CorVel's Financial Performance CorVel Corporation (NASDAQ: CRVL) recently unveiled impressive results for the quarter and fiscal year, showcasing strong revenue gains and enhanced earnings metrics. The quarterly revenue hit $232 million, a notable rise from $207 million compared to the same quarter last year. This upward trend is mirrored across the fiscal...
Continue Reading
IQAX Achieves Interoperability Approval for eBL Solutions
IQAX eBL Interoperability Approval Highlights IQAX Limited has made significant strides in enhancing its electronic bill of lading (eBL) solution by receiving official approval from the International Group of P&I Clubs (IG P&I Clubs). This approval affirms the capabilities of IQAX eBL's interoperable addendum, empowering users to perform eBL transactions across different...
Continue Reading